SK Bioscience (Korea) Price on September 2, 2024
| 302440 Stock | 47,100 2,000 4.07% |
If you're considering investing in 302440 Stock, it is important to understand the factors that can impact its price. As of today, the current price of SK Bioscience stands at 47,100, as last reported on the 1st of December, with the highest price reaching 49,100 and the lowest price hitting 47,050 during the day. SK Bioscience retains Efficiency (Sharpe Ratio) of -0.0732, which indicates the firm had a -0.0732% return per unit of price deviation over the last 3 months. SK Bioscience exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SK Bioscience's Risk Adjusted Performance of (0.07), standard deviation of 2.51, and Mean Deviation of 1.89 to confirm the risk estimate we provide.
302440 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
302440 |
Sharpe Ratio = -0.0732
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 302440 |
Estimated Market Risk
| 2.58 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average SK Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SK Bioscience by adding SK Bioscience to a well-diversified portfolio.
SK Bioscience Valuation on September 2, 2024
It is possible to determine the worth of SK Bioscience on a given historical date. On September 2, 2024 302440 was worth 55800.0 at the beginning of the trading date compared to the closed value of 53800.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of SK Bioscience stock. Still, in general, we apply an absolute valuation method to find SK Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of SK Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against SK Bioscience's related companies.
| Open | High | Low | Close | Volume | |
| 54,900 | 55,500 | 54,500 | 55,500 | 101,995 | |
09/02/2024 | 55,800 | 55,900 | 53,600 | 53,800 | 108,995 |
| 54,200 | 54,400 | 53,000 | 53,000 | 63,581 |
| Backtest SK Bioscience | | | SK Bioscience History | | | SK Bioscience Valuation | Previous | Next |
SK Bioscience Trading Date Momentum on September 2, 2024
| On September 03 2024 SK Bioscience Co was traded for 53,000 at the closing time. The highest price during the trading period was 54,400 and the lowest recorded bid was listed for 53,000 . The volume for the day was 63.6 K. This history from September 3, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 1.49% . The trading price change to the current price is 0.37% . |
SK Bioscience Fundamentals Correlations and Trends
By evaluating SK Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among SK Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. 302440 financial account trend analysis is a perfect complement when working with valuation or volatility modules.About SK Bioscience Stock history
SK Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 302440 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in SK Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing SK Bioscience stock prices may prove useful in developing a viable investing in SK Bioscience
SK Bioscience Stock Technical Analysis
SK Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
SK Bioscience Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
SK Bioscience Co cannot be verified against its exchange. Please verify the symbol is currently traded on Korea Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
SK Bioscience December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how SK Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SK Bioscience shares will generate the highest return on investment. By undertsting and applying SK Bioscience stock market strength indicators, traders can identify SK Bioscience Co entry and exit signals to maximize returns
SK Bioscience Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for SK Bioscience's price direction in advance. Along with the technical and fundamental analysis of 302440 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of 302440 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | 23.51 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for 302440 Stock analysis
When running SK Bioscience's price analysis, check to measure SK Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SK Bioscience is operating at the current time. Most of SK Bioscience's value examination focuses on studying past and present price action to predict the probability of SK Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SK Bioscience's price. Additionally, you may evaluate how the addition of SK Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |